Clearing the Fog: Is Hydroxychloroquine Effective in Reducing COVID-19 Progression (COVID-19)

Clinical Trial ID NCT04491994

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT04491994

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents 2020 4.49
2 Design and synthesis of hydroxyferroquine derivatives with antimalarial and antiviral activities. J Med Chem 2006 0.82
3 Re: Marmor et al.: American Academy of Ophthalmology Statement: Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 Revision). (Ophthalmology 2016;123:1386-1394). Ophthalmology 2017 0.75
Next 100